Navigation Links
Club cells are 'bad guys' during flu infection
Date:8/18/2014

A specialized subset of lung cells can shake flu infection, yet they remain stamped with an inflammatory gene signature that wreaks havoc in the lung, according to a study published in The Journal of Experimental Medicine.

Seasonal flu is caused by influenza virus, which can infect a variety of cell types in the lung. Infected cells are typically destroyed by the virus itself or by immune cells that attack infected cells. The resulting inflammation can linger on long after the virus has been eliminated leading to persistent symptoms and, in some cases, severe tissue damage.

Club cells are specialized cells that normally protect against inhaled microbes and pollutants. However, researchers from the Icahn School of Medicine at Mount Sinai in New York show that club cells are bad guys during flu infection. Although they are able to rid themselves of the flu virus, club cells fail to switch off expression of inflammatory genes causing prolonged pathology in the lungs even after the virus has been contained. Depletion of surviving club cells lessened destructive lung damage in flu-infected mice.

The authors confirm that human club cells show a similar inflammatory response to flu infection, so targeting club cells might be a strategy to shorten the duration of flu symptoms in humans.


'/>"/>
Contact: Rita Sullivan King
news@rupress.org
212-327-8603
Rockefeller University Press
Source:Eurekalert  

Page: 1

Related medicine news :

1. Researchers identify a mechanism that stops progression of abnormal cells into cancer
2. How breast cancer usurps the powers of mammary stem cells
3. Scientists Inch Closer Toward Using Stem Cells for Spinal Injuries
4. Stem cells show promise for stroke in pilot study
5. Growing human GI cells may lead to personalized treatments
6. Weakness of leukemic stem cells discovered
7. Weakness of leukaemic stem cells discovered
8. Most Cosmetic Procedures Based on Stem Cells Are Bogus, Experts Say
9. Molecular gate that could keep cancer cells locked up
10. Master HSF supports reprogramming of normal cells to enable tumor growth and metastasi
11. A new way to generate insulin-producing cells in Type 1 diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Club cells are 'bad guys' during flu infection
(Date:9/19/2014)... (PRWEB) September 19, 2014 Atlantic Information ... the authoritative AIS’s Directory of Health Plans — is ... Trends and Data: 2014-2015. The latest edition of the ... re-shaping the health care industry. , With valuable ... issues — from benefit design and management strategies to ...
(Date:9/19/2014)... Internationally acclaimed prosthodontist and presenter Dr. ... conference tomorrow. , Dr. Jivraj, founder of a ... Dental Art Institute, will speak about All-on-4™ dental ... Aspects of Graft Less Solutions.” He is speaking at ... Landmark Hotel & Conference Centre in Vancouver, British Columbia, ...
(Date:9/19/2014)... Germany (PRWEB) September 19, 2014 ... that its new ND® Infusion Catheter is ... of Frankfurt. , The study commenced on September 4th, ... The use of the new catheter demonstrated a number ... known as stem cells. “We are at the forefront ...
(Date:9/19/2014)... 2014 Cancer researchers in Japan have ... on where mesothelioma develops in the body. Click ... this important research. , Doctors with Nara Medical ... pleural mesothelioma (on the lung lining) and those ... study suggests that the pathway of the genetic abnormality ...
(Date:9/19/2014)... 2014 In their latest article ... home care options, Seniors Guide has published, ... http://www.HomeCareChoice.com - their website for finding ... North Carolina, Ohio, and Indiana. , Seniors Guide ... services offered, training and education, and also inquiring ...
Breaking Medicine News(10 mins):Health News:New Book from Atlantic Information Provides Insights Into Trends in the Health Care Industry 2Health News:Ventura Tooth Replacement and Restoration Expert to Speak at Vancouver Conference Tomorrow About All-on-4™ Procedure 2Health News:Ventura Tooth Replacement and Restoration Expert to Speak at Vancouver Conference Tomorrow About All-on-4™ Procedure 3Health News:Ventura Tooth Replacement and Restoration Expert to Speak at Vancouver Conference Tomorrow About All-on-4™ Procedure 4Health News:Ventura Tooth Replacement and Restoration Expert to Speak at Vancouver Conference Tomorrow About All-on-4™ Procedure 5Health News:First-in-man procedure utilizes a new method of stem cell delivery 2Health News:First-in-man procedure utilizes a new method of stem cell delivery 3Health News:New Study Finds Link Between Genes and Mesothelioma Location, Reports Surviving Mesothelioma 2Health News:Seniors Guide Offers Advice on How to Find the Right Home Health Care Agency 2
... Cholesterol-lowering meds seem to shield against troublesome complication, study ... patients who take cholesterol-lowering statins before cardiac surgery may ... study finds. , Depending on variables such as ... 47 percent of people experience this condition of confusion ...
... mechanics can lead to pain and stiffness , , THURSDAY, Dec. 25 ... back. , To ease the backaches that may have come ... and stretching and straining to put up holiday decorations -- and that ... Association offers a 10-step guide: , Zero ...
... these cells more closely mimic those of humans , , ... found a formula to capture indefinitely the basic embryonic ... cells. , If the findings hold up, scientists ... readily produced, genetically altered strains of rats. As humans ...
... conflicting news reports on the ongoing Baxter Heparin blood thinner controversy. ... of death among several patients, but the agency has also alleged ... patients. , ... Denver, CO (PRWEB) December 25, 2008 ...
... Weber Denture Liner kit is designed to answer questions often ... my loose denture fit better, give me more comfort and ... use of this new always-soft Weber Denture Liner. All ... fit better with this new (Patent Pending) invention. The Weber ...
... at risk for dementia, Parkinsons, researchers say , , WEDNESDAY, ... causes them to kick or cry out during deep sleep ... new Canadian study suggests. , "It,s basically a disorder where ... Dr. Ronald B. Postuma, of McGill University in Montreal. "When ...
Cached Medicine News:Health News:Tips to Ease an Aching Back 2Health News:Scientists May Isolate Stem Cells From Rats, Other Mammals 2Health News:LegalView Updates its Baxter Heparin Information Portal with Conflicting News Reports on the Possible Dangers 2Health News:LegalView Updates its Baxter Heparin Information Portal with Conflicting News Reports on the Possible Dangers 3Health News:LegalView Updates its Baxter Heparin Information Portal with Conflicting News Reports on the Possible Dangers 4Health News:New Product Makes Loose Dentures Fit Better 2Health News:New Product Makes Loose Dentures Fit Better 3Health News:Sleep Disorder Could Signal Neurological Disease 2
(Date:9/18/2014)... LONDON , Sept. 18, 2014 /PRNewswire/ ... Competition for innovation, increasing clinical development costs, new ... the fast-changing environment are important factors driving industry ... clinical trial costs continue to rise due to ... Studies conducted by industry think tanks suggest each ...
(Date:9/18/2014)... -- Decision Resources Group finds that Regeneron,s Eylea, the most ... wet AMD, is equally likely to be covered on ... is the standard of care for wet AMD. Of ... not identify a clear clinical or economic advantage with ... be listed on tier 1 or 2 on Medicare ...
(Date:9/18/2014)... 18, 2014  Zacks.com announces the list of stocks ... Equity Research analysts discuss the latest news and events ... in the blog include the Avanir Pharmaceuticals (Nasdaq: AVNR ... - Free Report ), Orexigen (Nasdaq: OREX - ... Report ) and Gilead (Nasdaq: GILD - Free ...
Breaking Medicine Technology:Patient Recruitment in Asia Biotech and Pharma Companies 2Patient Recruitment in Asia Biotech and Pharma Companies 3Regeneron's Eylea and Genentech's Lucentis Are Equally Likely to be Covered on Commercial and Medicare Advantage Plans for Wet AMD 2Regeneron's Eylea and Genentech's Lucentis Are Equally Likely to be Covered on Commercial and Medicare Advantage Plans for Wet AMD 3The Zacks Analyst Blog Highlights: Avanir Pharmaceuticals, NPS Pharmaceuticals, Orexigen, Medivation and Gilead 2The Zacks Analyst Blog Highlights: Avanir Pharmaceuticals, NPS Pharmaceuticals, Orexigen, Medivation and Gilead 3The Zacks Analyst Blog Highlights: Avanir Pharmaceuticals, NPS Pharmaceuticals, Orexigen, Medivation and Gilead 4The Zacks Analyst Blog Highlights: Avanir Pharmaceuticals, NPS Pharmaceuticals, Orexigen, Medivation and Gilead 5The Zacks Analyst Blog Highlights: Avanir Pharmaceuticals, NPS Pharmaceuticals, Orexigen, Medivation and Gilead 6
... Calif., Nov. 8, 2011 ICU Medical, Inc. (NASDAQ: ... presented this past weekend at the 36th annual meeting ... Anaheim, CA has shown that the company,s ChemoClave® closed ... and patients safe from accidental exposure to hazardous drugs ...
... Nov. 8, 2011 Boston Scientific Corporation (NYSE: ... PLATINUM Long Lesion trial, demonstrating excellent outcomes for the ... patients with long coronary lesions.  Results were presented today ... in La Jolla, California, and Co-Principal Investigator of the ...
Cached Medicine Technology:Breaking Study: ICU Medical, Inc. ChemoClave® System Costs Less to Implement than any Closed System Transfer Device for the Safe Handling of Hazardous Drugs 2Breaking Study: ICU Medical, Inc. ChemoClave® System Costs Less to Implement than any Closed System Transfer Device for the Safe Handling of Hazardous Drugs 3Breaking Study: ICU Medical, Inc. ChemoClave® System Costs Less to Implement than any Closed System Transfer Device for the Safe Handling of Hazardous Drugs 4Boston Scientific's PROMUS Element™ Platinum Chromium Stent Demonstrates Excellent Outcomes in Patients With Long Coronary Lesions 2Boston Scientific's PROMUS Element™ Platinum Chromium Stent Demonstrates Excellent Outcomes in Patients With Long Coronary Lesions 3Boston Scientific's PROMUS Element™ Platinum Chromium Stent Demonstrates Excellent Outcomes in Patients With Long Coronary Lesions 4
Lyphochek Hemoglobin A2 Control is a human whole blood based product designed to monitor the performance of automated and manual procedures for the measurement of hemoglobin variants, including Hemog...
Liquichek Hematology Control (A) is an assayed hematology control for evaluating the performance of Abbott Cell-Dyn 1600, 1700, 3000, 3500 and 3700 analyzers with 5-part differential technology....
... Control is a bilevel liquid ... performance of the most widely ... A weak positive and a ... monitor the performance of your ...
Liquichek™ Ethanol/Ammonia Control is a liquid product used to monitor ethanol and ammonia test procedures in the clinical laboratory....
Medicine Products: